| Net Cash Provided by (Used in) Operating Activities |
$428,101 |
USD |
62% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$233,510 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$280,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
112,282,745 |
shares |
7.2% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$85,409 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$23,851 |
USD |
-73% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$7,710,300 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$8,884,800 |
USD |
-0.85% |
Q4 2024 |
FY 2024 |
| Depreciation |
$425,226 |
USD |
-82% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,358,900 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,174,500 |
USD |
-42% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$337,531 |
USD |
-55% |
Q3 2025 |
Q3 2025 |